GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaNutra SpA (MIL:PHN) » Definitions » EV-to-Revenue

PharmaNutra SpA (MIL:PHN) EV-to-Revenue : 4.44 (As of Jun. 18, 2024)


View and export this data going back to 2017. Start your Free Trial

What is PharmaNutra SpA EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, PharmaNutra SpA's enterprise value is €451.5 Mil. PharmaNutra SpA's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €101.7 Mil. Therefore, PharmaNutra SpA's EV-to-Revenue for today is 4.44.

The historical rank and industry rank for PharmaNutra SpA's EV-to-Revenue or its related term are showing as below:

MIL:PHN' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.46   Med: 6.37   Max: 19.76
Current: 4.44

During the past 9 years, the highest EV-to-Revenue of PharmaNutra SpA was 19.76. The lowest was 3.46. And the median was 6.37.

MIL:PHN's EV-to-Revenue is ranked worse than
74.63% of 1017 companies
in the Drug Manufacturers industry
Industry Median: 2.25 vs MIL:PHN: 4.44

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-18), PharmaNutra SpA's stock price is €46.25. PharmaNutra SpA's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €10.48. Therefore, PharmaNutra SpA's PS Ratio for today is 4.41.


PharmaNutra SpA EV-to-Revenue Historical Data

The historical data trend for PharmaNutra SpA's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaNutra SpA EV-to-Revenue Chart

PharmaNutra SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 3.98 5.90 10.20 7.09 5.38

PharmaNutra SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.05 6.34 4.81 5.38 5.46

Competitive Comparison of PharmaNutra SpA's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaNutra SpA's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaNutra SpA's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaNutra SpA's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where PharmaNutra SpA's EV-to-Revenue falls into.



PharmaNutra SpA EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

PharmaNutra SpA's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=451.477/101.691
=4.44

PharmaNutra SpA's current Enterprise Value is €451.5 Mil.
PharmaNutra SpA's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €101.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaNutra SpA  (MIL:PHN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

PharmaNutra SpA's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=46.25/10.479
=4.41

PharmaNutra SpA's share price for today is €46.25.
PharmaNutra SpA's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €10.48.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaNutra SpA EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of PharmaNutra SpA's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaNutra SpA (MIL:PHN) Business Description

Traded in Other Exchanges
Address
Via Delle Lenze, 216/b, Pisa, ITA, 56122
PharmaNutra SpA is a pharmaceutical company. It is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. Its products include SiderAL Folic, UltraMag, Cetilar, Gestalys DHA, Bonecal, Nasalt, Novomega, SiderAL, CardioSiderAL, DiKappa2, SiderAL Forte, and others. The company operates in Europe, the Middle East, the Far East, Asia, the United States, and Africa.

PharmaNutra SpA (MIL:PHN) Headlines

No Headlines